M&T Bank Corp Biogen Inc. Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Biogen Inc. stock. As of the latest transaction made, M&T Bank Corp holds 17,096 shares of BIIB stock, worth $2.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,096

Previous 16,567 3.19%

Holding current value

$2.97 Million

Previous $3.57 Million 10.95%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$190.52 - $236.72 $100,785 - $125,224	529 Added 3.19%	17,096 $3.96 Million
Q1 2024 May 07, 2024	SELL	$212.02 - $267.71 $84,595 - $106,816	-399 Reduced 2.35%	16,567 $3.57 Million
Q4 2023 Feb 06, 2024	SELL	$222.59 - $267.94 $58,541 - $70,468	-263 Reduced 1.53%	16,966 $4.39 Million
Q3 2023 Nov 02, 2023	BUY	$253.3 - $285.89 $1,519 - $1,715	6 Added 0.03%	17,229 $4.43 Million
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $15,138 - $17,493	55 Added 0.32%	17,223 $4.91 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $386,892 - $440,848	-1,508 Reduced 8.07%	17,168 $4.77 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $20,447 - $24,844	-81 Reduced 0.43%	18,676 $5.17 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $109,054 - $132,503	432 Added 2.36%	18,757 $5.19 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $221,362 - $305,239	1,137 Added 6.62%	18,325 $4.84 Million
Q2 2022 Aug 05, 2022	SELL	$187.54 - $223.02 $95,832 - $113,963	-511 Reduced 2.89%	17,188 $3.48 Million
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $80,414 - $101,318	-415 Reduced 2.29%	17,699 $3.73 Million
Q4 2021 Feb 07, 2022	SELL	$223.92 - $287.77 $981,889 - $1.26 Million	-4,385 Reduced 19.49%	18,114 $4.35 Million
Q3 2021 Oct 28, 2021	SELL	$282.99 - $369.05 $594,279 - $775,005	-2,100 Reduced 8.54%	22,499 $6.37 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $2.8 Million - $4.48 Million	-10,802 Reduced 30.51%	24,599 $8.52 Million
Q1 2021 May 06, 2021	SELL	$242.95 - $284.63 $8.51 Million - $9.97 Million	-35,039 Reduced 49.74%	35,401 $9.9 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $894,244 - $1.35 Million	-3,785 Reduced 5.1%	70,440 $17.2 Million
Q3 2020 Nov 06, 2020	SELL	$264.77 - $305.71 $204,402 - $236,008	-772 Reduced 1.03%	74,225 $21.1 Million
Q2 2020 Jul 29, 2020	SELL	$258.66 - $342.55 $108,637 - $143,871	-420 Reduced 0.56%	74,997 $20.1 Million
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $874,031 - $1.11 Million	3,251 Added 4.5%	75,417 $23.9 Million
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $62,937 - $86,964	-286 Reduced 0.39%	72,166 $21.4 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $135,247 - $151,693	622 Added 0.87%	72,452 $16.9 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $1.24 Million - $1.37 Million	-5,662 Reduced 7.31%	71,830 $16.8 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $205,874 - $322,012	-950 Reduced 1.21%	77,492 $18.3 Million
Q4 2018 Feb 01, 2019	SELL	$278.5 - $352.75 $1.37 Million - $1.74 Million	-4,936 Reduced 5.92%	78,442 $23.6 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $1.46 Million - $1.91 Million	-4,968 Reduced 5.62%	83,378 $29.5 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $1.29 Million - $1.54 Million	5,026 Added 6.03%	88,346 $25.6 Million
Q1 2018 May 04, 2018	BUY	$260.13 - $367.91 $1.57 Million - $2.22 Million	6,037 Added 7.81%	83,320 $22.8 Million
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $565,442 - $633,338	1,838 Added 2.44%	77,283 $24.6 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $271,590 - $318,480	966 Added 1.3%	75,445 $23.6 Million
Q2 2017 Aug 11, 2017	BUY	N/A	74,479	74,479 $20.2 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account